Insider Trading activities of Avexis, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avexis, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avexis, Inc. since year 2005. Table 2 shows the detailed insider transactions of Avexis, Inc. since 2005. The reporting company's ticker symbol is AVXS. The reporting company's CIK number is 1652923.
The total value of stock buying since 2005 is $14,705,330.
The total value of stock sales since 2005 is $12,589,334.
The total value of stock option exercises since 2005 is $230,151.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Avexis, Inc. (AVXS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 16,780 $1,705,446 1,780 $32,876
2017-09 0 $0 1,780 $166,287 1,780 $32,876
2017-08 0 $0 1,780 $163,706 1,780 $32,876
2017-07 0 $0 1,780 $146,031 1,780 $32,876
2017-06 0 $0 1,780 $126,557 1,780 $32,876
2017-05 0 $0 1,780 $145,723 1,780 $32,876
2017-04 0 $0 1,781 $135,587 1,781 $32,895
2016-09 0 $0 289,855 $9,999,997 0 $0
2016-02 491,495 $9,829,900 0 $0 0 $0
2015-09 263,822 $4,875,430 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Avexis, Inc. insiders (AVXS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-09 Kaspar Brian K. (Chief Scientific Officer) Sale 15,000 102.09 1,531,425
2017-10-02 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 97.77 174,021
2017-10-02 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-09-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 93.42 166,287
2017-09-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-08-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 91.97 163,706
2017-08-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-07-03 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 82.04 146,031
2017-07-03 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-06-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 71.10 126,557
2017-06-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-05-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,780 81.87 145,723
2017-05-01 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,780 18.47 32,876
2017-04-03 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Sale 1,781 76.13 135,587
2017-04-03 Nagendran Sukumar (Sr. VP & Chief Medical Officer) Option Ex 1,781 18.47 32,895
2016-09-13 Manning Paul B (Director) Sale 289,855 34.50 9,999,997
2016-02-17 Deerfield Private Design Fund Iii, L.p. Buy 486,495 20.00 9,729,900
2016-02-10 Knudten Andrew F. (SrVP/Manufacture&Supply Chain) Buy 5,000 20.00 100,000
2015-09-03 Deerfield Private Design Fund Iii, L.p. Buy 263,822 18.48 4,875,430

Insider trading activities including stock purchases, stock sales, and option exercises of AVXS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avexis, Inc. (symbol AVXS, CIK number 1652923) see the Securities and Exchange Commission (SEC) website.